Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 476
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
Jim Cramer fears SpaceX's IPO could be 'destructive' for the rest of market
A state banquet, selfies with Musk and Huang's noodle run: The spectacle of Trump's Beijing visit
Wall Street and Main Street face off next week with Nvidia, consumer earnings. Here's what's ahead 
Sundheim's D1 Capital bought several tech stocks last quarter — with one big exception
What you need to know about Nvidia competitor Cerebras after wild IPO
Fellow Californians, How are You Handling the Governor Primary?
Book: The Player of Games
Book: Don Quixote, chapter 3
For better or worse, investors are living through Trump’s stock market. Here's why
Creator content made the main stage at TV's 'upfront' pitches — and not just for YouTube